Panel: The state of the CGT industry & turning the future into action

This session will explore the current state of the CGT industry, with a focus on Europe’s evolving role amid global shifts. In a climate where research ecosystems face mounting uncertainty — particularly following moves in the U.S. to scale back federal support for scientific innovation, Europe must sharpen its competitiveness to secure its leadership in advanced therapies. We will examine emerging trends, key market dynamics, and the urgent need for Europe to overcome challenges around scalability, affordability, and patient access. The discussion will highlight how external pressures are reshaping Europe’s strategic priorities — and what actions are needed now to turn today’s challenges into tomorrow’s leadership in CGT.